López TS

Language: Spanish
References: 15
Page:
PDF size: 291.15 Kb.

ABSTRACT

Takotsubo syndrome is defined as an alteration of the contraction of the heart, with a typical apical bulging and basal hypercontractility, in which hyperactivity of the amygdala and overstimulation by catecholamines play an important role, so it is common to have a physical or emotional stressful trigger. It mainly affects postmenopausal women, and its form of presentation is mainly with chest pain, like an ACS (acute coronary syndrome), it should differ mainly from a MINOCA (acute myocardial infarction without obstructive coronary injury) for this the diagnostic algorithm using the interTAK score is useful. Within its treatment is essential the stratification of risk into high or low risk, monitoring and ultrasound initially daily, due to risk of arrhythmias and other complications, each of these is treated individually. Treatment with beta-blockers is generally recommended in high-risk patients and/or with decreased LVEF (left ventricular ejection fraction); On the other hand, drugs that due to the pathophysiology of the syndrome could be counterproductive, such as inotropes and sympathomimetics, should be avoided. Subsequently, ultrasound should be followed up initially at 6 and 12 months and then performed annually. In-hospital mortality is up to 5%, however, the long-term prognosis is quite good, although some symptoms may persist, and recurrences are infrequent (although described).

REFERENCES

1. Cruz PF, Jiménez MC, Webb WK, et al. Cardiomiopatía de Takotsubo. Rev Clin Esc Med. 2019;9(5):28-33.

2. Reeder GS, Prasad MA. Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy. In: UpToDate, William J (Ed), UpToDate, Waltham, MA. (consulted Set 01, 2022).

3. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, eds. Braunwald. Tratado de Cardiología: Texto de Medicina Cardiovascular. 11a ed. Elsevier; 2019.

4. Omerovic E, Citro R, Bossone E, Redfors B, Backs J, Bruns B, Ciccarelli M, Couch LS, Dawson D, Grassi G, Iacoviello M, Parodi G, Schneider B, Templin C, Ghadri JR, Thum T, Chioncel O, Tocchetti CG, van der Velden J, Heymans S, Lyon AR. Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system. Eur J Heart Fail. 2022;24:257-273. Consulted 2022 Oct 20. Doi: https://doi.org/10.1002/ejhf.2400

5. Ghadri JR, Wittstein IS, Prasad A, Sharkey S, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. European Heart Journal. 2018;29(22):2032–2046. Doi: https://doi.org/10.1093/eurheartj/ehy076

6. Radfar A, Abohashem S, Osborne MT, Wang Y, Dar T, Hassan MZ, et al. Stress-associated neurobiological activity associates with the risk for and timing of subsequent Takotsubo syndrome. European Heart Journal. 2021 May 14;42(19):1898–1908. Doi: https://doi.org/10.1093/eurheartj/ehab029

7. DynaMed. Takotsubo Syndrome. EBSCO Information Services. Accessed Nov 09, 2022. Available from: https://www.dynamed.com/condition/takotsubo-syndrome

8. Citro R, Okura H, Ghadri JR, Izumi C, et al. EACVI Scientific Documents Committee, Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE). European Heart Journal - Cardiovascular Imaging. 2020;21(11):1184–1207. Doi: https://doi.org/10.1093/ehjci/jeaa149

9. Fröhlich GM, Schoch B, Schmid F, Keller P, Sudano I, Lüscher TF, Noll G, Ruschitzka F, Enseleit F. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Int J Cardiol. 2012 Feb 09;154(3):328-32. Doi: 10.1016/j.ijcard.2011.09.077

10. López-Pais J, Izquierdo Coronel BI, Raposeiras-Roubin S, Álvarez L, Uribarri A, Almendro-Delia M, Galan D, Vedia O, López D. Differences between Takotsubo and the working diagnosis of myocardial infarction with non-obstructive coronaryarteries. European Heart Journal. 2021 Oct;42(1):ehab724.1495. Doi: https://doi.org/10.1093/eurheartj/ehab724.1495

11. Crea F, Niccoli G, MD. Myocardial infarction with no obstructive coronary atherosclerosis. In: UpToDate, Kaski JC (Ed), UpToDate, Waltham, MA. (Consulted Oct 20, 2022).

12. Maréchaux S, Goldstein P, Girardie P, Ennezat PV. Contractile pattern of inverted Takotsubo cardiomyopathy: illustration by two-dimensional strain. European Journal of Echocardiography. 2009;10(2):332-333. Doi: https://doi.org/10.1093/ejechocard/jen250

13. Kagiyama N, Okura H, Kume T, Hayashida A, Yoshida A. Isolated right ventricular takotsubo cardiomyopathy. European Heart Journal - Cardiovascular Imaging. 2015;26(3):285. Doi: https://doi.org/10.1093/ehjci/jeu207

14. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison. Principios de Medicina Interna. 20th ed. McGraw-Hill; 2018.

15. Ghadri JR, Y-Hassan S, Lüscher TF, Templin C, et al. Pheochromocytoma triggers takotsubo syndrome. European Heart Journal. 2019 Jun;40(21):1990. Doi: https://doi.org/10.1093/eurheartj/ehz084